| Prev Close | 298.47 |
| Day Low/High | 296.01 / 302.54 |
| 52 Wk Low/High | 208.07 / 300.99 |
| Avg Volume | 3.37M |
UnitedHealth Group Inc. (UNH)
300.53
NYSE : Health Services
| Exchange | NYSE |
| Shares Outstanding | 947.41M |
| Market Cap | 282.77B |
| P/E Ratio | 21.71 |
| Div & Yield | 4.32 (1.39%) |
Latest News
Target Provides an Excuse for Selling but Underlying Support Remains Very Strong
Earnings reports are solid but this overbought market is looking for a good reason to consolidate a big move.
Jim Cramer: Why the Tech Stocks Are Back in Favor
The big tech names are once again surging, and as long as they keep their noses clean, that should continue.
My Pick for 2020? You Won't Believe It's Been on Your Screen All Along
This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.
UNH Passes Checkup, but Not With Flying Colors
Despite fluff and puff of UNH's analysts' day, little here screams for getting in right now.
3 Thoughts About UnitedHealth and My Trade Idea
There is no doubt in my mind that the firm is executing at a high level.
UnitedHealth Group Can Pull Back in the Short Run So Look to Buy the Dip
Time to review the charts and indicators.
Jim Cramer: These 2 Stocks Are Soaring, and It Is All About the Democratic Race
UnitedHealth Group and JPMorgan are both bucking other trends to rise as more moderate leanings start to dominate the Democratic horse race.
UnitedHealth Group Is Poised for an Upside Breakout
Prices have rocketed higher since early October.
Jim Cramer: Here's Why the Market Hasn't Stopped Rallying
These are the 10 reasons why we keep going up, despite all the bad news.
Drug Companies Are a Political Football, Trading Amgen: Market Recon
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
Shorting the Dow at 27,000 May Not Be So Crazy
After seeing the idea raised -- and derided -- I found that the Dow has been over 27,000 twice this year and each time it did this....
Jim Cramer: Here's How You Get a Not as Bad as Feared Quarter
I have the answer behind the conundrum that forces stocks up that should be going lower.
Jim Cramer: Netflix and CSX Lead the 'NABAF' Earnings Story
These stocks's earnings were 'not as bad as feared,' and here are some more names that pushed the NABAF narrative.
Jim Cramer: The Market Is Lapping Up These Stocks
There are plenty of senior growth companies that can still move higher.
Markets Bet on Growth, 3 Month/10 Year Spread, Trading Nvidia: Market Recon
The Fed is doing this right. Let me repeat... the Fed is not screwing this up.
Key Market Observations
As mentioned earlier, breadth was only 2-1 positive with UnitedHealth , JPMorgan and Johnson & Johnson responsible for a large portion of the market's gains. Bond yields rose, aiding the rate-sensitive banks (who generally met expectations). FANG ha...
Advancers Over Decliners
"Only" about 2-1 advancers over decliners as UnitedHealth Care , JP Morgan and Johnson & Johnson account for a disproportionate amount of the market's rally.
Valuation and 2 Names to Watch Into Earnings: Market Recon
Citigroup and Lululemon are on the radar this morning.
UnitedHealth Group Is Looking Stronger as Support Has Held
UNH reports earnings on Tuesday.
Looking for Yield? Buy These Closed-End Funds and REITs
These three CEFs are particularly appealing right now, with overhyped fears making them unusually cheap.
Avoid the 'Herd' With This Trio of Benjamin Graham-Style Value Stocks
Quintessential investor Graham described the stock market in the short term as an imperfect voting machine.
The Mixed Picture on UnitedHealth Group Warrants Closer Monitoring
Let's get the charts and indicators in for a check up.
Jim Cramer: Welcome to a Market Filled With Fear
The impact of Elizabeth Warren is pretty much everywhere Thursday.
Fed's Next Move, Microsoft's Performance, Trading U.S. Bancorp: Market Recon
What the Fed needs to do in July is to cut the FFR by 25 basis points and put the balance sheet management (QT) program to bed two months early.
Railroaded Transports, Musk's AI Musings and Microsoft at Hand: Market Recon
And just why do we have a federal debt ceiling, anyway? An argument for doing away with it.
Jim Cramer: Don't Play Earnings Season, Invest in It
Here are my five rules for handling earnings season.
4 Earnings Reports to Watch This Week
Schwab, Domino's, Netflix and UnitedHealth are set to report their quarterly results.
